|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory of Muscle Reseach and Molecular Cardiology, Department for Internal Medicine III, University of Cologne, Cologne, Germany
2 Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany
3 Deutsches Herzzentrum, Technische Universitaet Muenchen, Munich, Germany
* To whom correspondence should be addressed. E-mail: Robert.Schwinger{at}medizin.uni-koeln.de.
The Na+/Ca2+ exchanger (NCX) may influence cardiac function depending on its predominant
mode of action - forward mode or reverse mode - during the contraction-relaxation cycle. The intracellular sodium concentration ([Na+]i), the duration of the action potential as well as the level of NCX protein expression regulate the mode of action of NCX. [Na+]i and NCX expression have been reported to be increased in human heart failure. Nevertheless, the consequences of an altered NCX expression in heart failure are still a matter of discussion. We aimed to characterize the influence of NCX expression on intracellular Ca2+ transport in rat
cardiomyocytes by adenoviral-mediated gene transfer. A 5-9 fold (dose-dependent) overexpression of the NCX protein was achieved after 48 h by somatic gene transfer (Ad.NCX.GFP) versus control (Ad.GFP). NCX activity, determined by Na+ gradient-dependent 45Ca2+-uptake, was significantly increased. Protein expression of SERCA, phospholamban and calsequestrin were unaffected by NCX-overexpression. Fractional shortening (FS) of isolated cardiomyocytes was significantly increased at low stimulation rates in Ad.NCX.GFP. Following step-wise enhancing frequency of stimulation to 3.0 Hz, FS remained unaffected in Ad.GFP, but
declined in Ad.NCX.GFP cells. The positive inotropic effect of the cardiac glycoside ouabain was less effective in Ad.NCX.GFP; whereas the positive inotropic effect of
-adrenergic stimulation remained unchanged. In conclusion, NCX overexpression results in a reduced cell
shortening at higher stimulation frequencies as well as after inhibition of the sarcolemmal Na+/K+ ATPase, i.e. in conditions with enhanced [Na+]i. At low stimulation rates increased NCX expression enhances both intracellular systolic Ca2+ and contraction amplitude.
This article has been cited by other articles:
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Banyasz, I. Lozinskiy, C. E. Payne, S. Edelmann, B. Norton, B. Chen, Y. Chen-Izu, L. T. Izu, and C. W. Balke Transformation of adult rat cardiac myocytes in primary culture Exp Physiol, March 1, 2008; 93(3): 370 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Saini and N. S. Dhalla Modification of intracellular calcium concentration in cardiomyocytes by inhibition of sarcolemmal Na+/H+ exchanger Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2790 - H2800. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Munch, K. Rosport, C. Baumgartner, Z. Li, S. Wagner, A. Bultmann, and M. Ungerer Functional alterations after cardiac sodium-calcium exchanger overexpression in heart failure Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H488 - H495. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Geibel, N. Flores-Herr, T. Licher, and H. Vollert Establishment of Cell-Free Electrophysiology for Ion Transporters: Application for Pharmacological Profiling J Biomol Screen, April 1, 2006; 11(3): 262 - 268. [Abstract] [PDF] |
||||
![]() |
H. Reuter, C. Pott, J. I. Goldhaber, S. A. Henderson, K. D. Philipson, and R. H.G. Schwinger Na+-Ca2+exchange in the regulation of cardiac excitation-contraction coupling Cardiovasc Res, August 1, 2005; 67(2): 198 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baek and M. Weiss Down-Regulation of Na+ Pump {alpha}2 Isoform in Isoprenaline-Induced Cardiac Hypertrophy in Rat: Evidence for Increased Receptor Binding Affinity but Reduced Inotropic Potency of Digoxin J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 731 - 739. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |